US Patent 8895745 Bicyclic heterocyclic compounds as FGFR inhibitors
Patent 8895745 was granted and assigned to Astex Therapeutics Limited on November, 2014 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8895745 Bicyclic heterocyclic compounds as FGFR inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
